Our finding that docetaxel can induce an increase of HER2 transcription and expression in a human prostate cancer model is paralleled by a release of HER2; detection of seric HER2 could be searched for in patients after docetaxel treatment. This evidence concerns the gene ERBB2 and prostate carcinoma.